Logo image of HNP

Huaneng Power International Inc (HNP) Stock Fundamental Analysis

NYSE:HNP - New York Stock Exchange, Inc. - US4433041005 - ADR

21.51  +0.41 (+1.94%)

Fundamental Rating

1

HNP gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 20 industry peers in the Independent Power and Renewable Electricity Producers industry. HNP has a bad profitability rating. Also its financial health evaluation is rather negative. HNP is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HNP has reported negative net income.
HNP Yearly Net Income VS EBIT VS OCF VS FCFHNP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20B -20B 40B

1.2 Ratios

Industry RankSector Rank
ROA -2.94%
ROE N/A
ROIC -2.04%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HNP Yearly ROA, ROE, ROICHNP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 5 -5 10 15

1.3 Margins

Industry RankSector Rank
OM -5.88%
PM (TTM) -6.52%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HNP Yearly Profit, Operating, Gross MarginsHNP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 20

More info and screens

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HNP is destroying value.
Compared to 1 year ago, HNP has about the same amount of shares outstanding.
HNP has a worse debt/assets ratio than last year.
HNP Yearly Shares OutstandingHNP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M
HNP Yearly Total Debt VS Total AssetsHNP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100B 200B 300B 400B

2.2 Solvency

Based on the Altman-Z score of 0.32, we must say that HNP is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 1.79 is on the high side and indicates that HNP has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Altman-Z 0.32
ROIC/WACC-0.34
WACC5.99%
HNP Yearly LT Debt VS Equity VS FCFHNP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50B 100B 150B

2.3 Liquidity

HNP has a Current Ratio of 0.53. This is a bad value and indicates that HNP is not financially healthy enough and could expect problems in meeting its short term obligations.
HNP has a Quick Ratio of 0.53. This is a bad value and indicates that HNP is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.47
HNP Yearly Current Assets VS Current LiabilitesHNP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50B 100B 150B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for HNP have decreased strongly by -351.05% in the last year.
The Revenue has grown by 22.88% in the past year. This is a very strong growth!
The Revenue has been growing by 8.17% on average over the past years. This is quite good.
EPS 1Y (TTM)-351.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-152.94%
Revenue 1Y (TTM)22.88%
Revenue growth 3Y6.4%
Revenue growth 5Y8.17%
Sales Q2Q%30.74%

3.2 Future

The Earnings Per Share is expected to grow by 45.74% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 6.50% on average over the next years.
EPS Next Y269.69%
EPS Next 2Y103.81%
EPS Next 3Y68.69%
EPS Next 5Y45.74%
Revenue Next Year20.1%
Revenue Next 2Y10.25%
Revenue Next 3Y8.82%
Revenue Next 5Y6.5%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HNP Yearly Revenue VS EstimatesHNP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50B 100B 150B 200B 250B
HNP Yearly EPS VS EstimatesHNP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 10 20 30 40

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

HNP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
HNP is valuated cheaply with a Price/Forward Earnings ratio of 6.93.
HNP is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.93
HNP Price Earnings VS Forward Price EarningsHNP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HNP Per share dataHNP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HNP's earnings are expected to grow with 68.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y103.81%
EPS Next 3Y68.69%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HNP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Huaneng Power International Inc

NYSE:HNP (7/7/2022, 9:41:55 PM)

21.51

+0.41 (+1.94%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)03-22 2022-03-22/amc
Earnings (Next)07-26 2022-07-26/dmh
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.44B
Analysts70.43
Price Target18.93 (-11.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-110.7%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.93
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B 0.54
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.31
EYN/A
EPS(NY)3.1
Fwd EY14.42%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS82.97
BVpS39.5
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.94%
ROE N/A
ROCE N/A
ROIC -2.04%
ROICexc N/A
ROICexgc -2.18%
OM -5.88%
PM (TTM) -6.52%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.53
Quick Ratio 0.47
Altman-Z 0.32
F-Score4
WACC5.99%
ROIC/WACC-0.34
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-351.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-152.94%
EPS Next Y269.69%
EPS Next 2Y103.81%
EPS Next 3Y68.69%
EPS Next 5Y45.74%
Revenue 1Y (TTM)22.88%
Revenue growth 3Y6.4%
Revenue growth 5Y8.17%
Sales Q2Q%30.74%
Revenue Next Year20.1%
Revenue Next 2Y10.25%
Revenue Next 3Y8.82%
Revenue Next 5Y6.5%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A